Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and Asthma
Status:
Terminated
Trial end date:
2008-02-28
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe, Asia, Oceania and the United States of America (USA).
This is a one-year clinical trial to compare the safety of inhaled preprandial human insulin
to subcutaneous insulin aspart in subjects with type 1 or 2 diabetes and asthma.